Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 111
Filter
1.
Am J Ophthalmol ; 257: 84-90, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37422203

ABSTRACT

PURPOSE: To examine the current causes of intraocular lens (IOL) explantation, compare various IOL explantation techniques, and assess the visual outcomes and complications. DESIGN: Retrospective comparative case series. PARTICIPANTS: A total of 175 eyes of 160 patients who underwent IOL exchange for a one-piece foldable acrylic IOL between January 2010 and March 2022 were covered by the research. Group 1 included 74 eyes from 69 patients in which the IOL was removed after being grasped, pulled, and refolded inside the main incision. Group 2 consisted of 66 eyes from 60 patients in which the IOL was removed by bisecting it, whereas group 3 included 35 eyes from 31 patients in which the IOL was removed by enlarging the main incision. MAIN OUTCOMES: Surgical indications, interventions, visual outcomes and refraction, and complications. RESULTS: The mean patient age was 66.1 ± 10.5 years. The mean time between primary surgery and IOL explantation was 57.0 ± 38.9 months. IOL dislocation (in 85 eyes, 49.5%) was the most common reason for IOL explantation. When the patients were examined in terms of both surgical indication groups and IOL removal techniques, corrected-distance visual acuity increased significantly in all subgroups (P < .001). The increase in astigmatism after surgery was 0.08 ± 0.13 diopters (D) in group 1, 0.09 ± 0.17 D in group 2, and 0.83 ± 0.29 D in group 3 (P < .001). CONCLUSIONS: The grasp, pull, and refold technique for IOL explantation provides a simpler surgery, less complication, and good visual outcomes.


Subject(s)
Lenses, Intraocular , Postoperative Complications , Humans , Middle Aged , Aged , Retrospective Studies , Postoperative Complications/etiology , Lenses, Intraocular/adverse effects , Eye, Artificial/adverse effects , Visual Acuity
2.
Klin Monbl Augenheilkd ; 240(8): 952-959, 2023 Aug.
Article in English, German | MEDLINE | ID: mdl-37567234

ABSTRACT

Differentiating between various intraocular lens (IOL) changes can be a challenge. In particular, certain IOL models carry the risk of late postoperative calcification. A major cause of IOL exchange surgery could be avoided if appropriate modifications were made during the IOL manufacturing process. The use of a hydrophilic acrylate carries the risk of IOL calcification, especially when a secondary procedure, such as a pars plana vitrectomy or other procedures using gas or air, is performed. In secondary IOL calcification, there is a wide range of opacification patterns, which are usually located in the centre on the anterior surface of the IOL or sometimes elsewhere. Often, granular deposits accumulate just below or on the surface of the IOL, leading to significant deterioration in visual quality and eventually requiring IOL exchange surgery. Therefore, in the case of eyes requiring secondary surgical intraocular intervention in the future, the use of hydrophilic IOLs should be critically evaluated. With regard to hydrophobic IOL materials, there are clear differences in the susceptibility to the formation of glistenings. Over time, there has been a significant decrease in glistening formation over the past 30 years due to optimisation of the material. With hydrophobic IOLs, special care should also be taken to avoid mechanical damage. In general, the only treatment option for functionally-impairing IOL opacification is surgical lens exchange, which carries potential risks of complications. In cases with a low degree of functional impairment, and especially in eyes with additional ocular diseases, it may be difficult to weigh the risk of additional surgery against the potential benefit. In some cases, it may be more appropriate not to perform an IOL exchange despite the IOL opacification. Recent visualisation methods that allow high-resolution analysis of the opacities in vivo and in vitro may be used in the future to estimate the functional effects of various IOL material changes on the optical quality.


Subject(s)
Calcinosis , Lenses, Intraocular , Phacoemulsification , Humans , Diagnosis, Differential , Lens Implantation, Intraocular , Postoperative Complications/diagnosis , Postoperative Complications/etiology , Eye, Artificial/adverse effects , Calcinosis/etiology
3.
Am J Ophthalmol ; 246: 86-95, 2023 02.
Article in English | MEDLINE | ID: mdl-36457226

ABSTRACT

PURPOSE: To determine the incidence and to document risk factors for intraocular lens (IOL) calcification after pseudophakic endothelial keratoplasty. METHODS: We retrospectively studied 2700 consecutive penetrating, anterior lamellar and endothelial keratoplasties carried out between December 1992 and June 2022 at the National Eye Hospital, Paris, France. DESIGN: Retrospective cohort study. RESULTS: All IOL calcification cases were associated with endothelial keratoplasty. Out of 588 endothelial keratoplasty procedures, 576 eyes were pseudophakic at the end of surgery. Fourteen cases of IOL calcification were observed during follow-up. The cumulative incidence of IOL calcification after endothelial keratoplasty was 4.5%±1.3% at 60 months. Hydrophilic acrylic IOL material (P < .001) and use of SF6 for anterior chamber tamponade (P = .001) were significantly and independently associated with the cumulative incidence of IOL calcification. CONCLUSION: The incidence of IOL calcifications seems to be around 5%. Ophthalmologists should avoid hydrophilic acrylic IOLs in patients with endothelial disorders. When the patient already has a hydrophilic IOL, SF6 should be avoided. The only effective treatment is IOL exchange.


Subject(s)
Calcinosis , Corneal Transplantation , Lenses, Intraocular , Humans , Retrospective Studies , Lenses, Intraocular/adverse effects , Corneal Transplantation/adverse effects , Eye, Artificial/adverse effects , Calcinosis/diagnosis , Calcinosis/etiology , Anterior Chamber/surgery
4.
Graefes Arch Clin Exp Ophthalmol ; 260(8): 2427-2431, 2022 Aug.
Article in English | MEDLINE | ID: mdl-35366081

ABSTRACT

BACKGROUND: The last definition of the post-enucleation socket syndrome (PESS) by Tyers and Collin-formulated almost 40 years ago in 1982-is predominantly based on the clinical characteristics and does not include the insights of newer studies into the pathophysiological mechanism of the PESS. METHODS: A systematic PubMed literature review regarding the pathophysiological mechanism of the PESS was performed, and results were comprised to give an overview of the current knowledge of the PESS including the exact pathophysiological mechanism. RESULTS: The primarily postulated pathophysiological mechanism of the PESS was the atrophy of orbital tissues, especially of fat, resulting in variable clinical findings. Newer studies using high-resolution computed tomography and magnetic resonance imaging or performing histopathological analyses found no orbital fat atrophy but rather a rotatory displacement of the orbital tissues from superior to posterior and from posterior to inferior together with the retraction of the extraocular muscles and a possible volume loss of the orbital implant by resorption if it is manufactured from hydroxyapatite. PESS results in a backward tilt of the superior fornix, a deep superior sulcus, a pseudo-ptosis, a lower eyelid elongation and laxity, a shallower inferior fornix, as well as enophthalmos and may lead to an inability of wearing ocular prostheses. CONCLUSIONS: A novel and comprehensive definition of the PESS is proposed: PESS is a multifactorial and variable syndrome caused by a rotatory displacement of orbital contents together with the retraction of the extraocular muscles and possible resorption of the orbital implant if it is manufactured from hydroxyapatite.


Subject(s)
Orbital Diseases , Orbital Implants , Atrophy , Eye Enucleation , Eye, Artificial/adverse effects , Humans , Hydroxyapatites , Orbital Diseases/diagnosis , Orbital Diseases/etiology , Orbital Diseases/surgery , Orbital Implants/adverse effects
5.
Eye (Lond) ; 36(4): 812-817, 2022 04.
Article in English | MEDLINE | ID: mdl-33888865

ABSTRACT

PURPOSE: Retrospective case series evaluating the efficacy and safety of implanting XtraFocus™ pinhole device in pseudophakic patients with irregular corneal astigmatism with concurrent or standalone iris defect. METHODS: Electronic case records were searched for: uncorrected distance visual acuities (UDVA) and corrected distance visual acuities (CDVA), automatic or manifest refraction and spherical equivalent (SE). All main outcomes were evaluated preoperatively and postoperatively at 1, 3, 6, 9 and 12 months, along with patients' satisfactory outcome and complications. RESULTS: Eleven pseudophakic eyes of 11 patients with a mean age of 54 (range 27-81) years were included. Median UDVA improved significantly from logMAR 0.7 (range 0.1-1.22) pre-operatively to 0.4 (range 0-1.3) at 1-month (p = 0.002); median CDVA remained unchanged at logMAR 0.4 (range 0-0.1) pre-operatively and 0.4 (range 0-0.8) at 1-month (p = 0.36). There were no significant statistical differences in both UDVA and CDVA between the post-operative periods. Ten patients (90.9%) had initial UDVA improvement at 1-month post op. Eight (72.7%) patients expressed satisfaction with improved vision or reduction of glare/halos. Three (27.3%) patients had unsatisfactory visual outcome resulting in 2 requested for implant explantation due to worsening of glare and distressing floaters. CONCLUSIONS: XtraFocus™ is effective in improving vision or reducing glare in pseudophakic patients with irregular corneal astigmatism or intragenic iris trauma, with over 70% expressed satisfactory outcome. Disturbing floaters and glare preclude its use in some resulting in implant explantation.


Subject(s)
Astigmatism , Corneal Diseases , Eye Injuries , Adult , Aged , Aged, 80 and over , Astigmatism/etiology , Astigmatism/surgery , Corneal Diseases/surgery , Eye Injuries/surgery , Eye, Artificial/adverse effects , Humans , Iris/surgery , Lens Implantation, Intraocular/methods , Middle Aged , Refraction, Ocular , Retrospective Studies , Treatment Outcome
6.
J Craniofac Surg ; 31(7): 1991-1994, 2020 Oct.
Article in English | MEDLINE | ID: mdl-32796299

ABSTRACT

PURPOSE: To investigate whether impaired lacrimal pump function is a possible cause of discharge in patients wearing an artificial eye compared with the remaining healthy eye. METHODS: Consecutive patients wearing unilateral ocular prosthesis for ≥6 months were included in this retrospective study. Excluded were any deformities of eyelids or nasal passage, socket complications such as entropion, ectropion, ptosis, infection, pyogenic granuloma, contracted socket, obstruction of nasolacrimal duct diagnosed with lacrimal irrigation and a difference greater than 2 mm in terms of protrusion between two eyes detected by Hertel exophthalmometry. Patients were asked to score the levels of tearing and mucopurulent discharge between 0 and 5 to assess lacrimal drainage function subjectively. Furthermore, dacryoscintigraphy was performed to assess the functional status of the lacrimal system objectively. RESULTS: Included were 32 subjects (12 females, 20 males; aged 32.94 ±â€Š17.62, range 13-78). Mean duration of prosthetic wearing 26.41 ±â€Š21.30 (6-72) months. The mean subjective scores of tearing and mucopurulent discharge were 1.56 ±â€Š1.67 and 1.94 ±â€Š1.63, respectively. The rate of functional stenosis was significantly higher in the anophthalmic socket side as compared to the healthy side (P = 0.002). The rates of a presac, preduct, and intraduct obstruction was notes as n = 9, n = 10, n = 1 and n = 0, n = 6, n = 2 in the anophthalmic side and the companion eye, respectively (P = 0.021). CONCLUSION: Compared to paired healthy eyes, the ocular prosthesis exhibited significantly higher rates of functional lacrimal duct obstruction, especially at the presac level. The alterations in orbital volume and tear film composition in addition to reduced corneal reflex blinking may lead to the failure of lacrimal pump function in artificial eyes.


Subject(s)
Anophthalmos/diagnostic imaging , Lacrimal Duct Obstruction , Adolescent , Adult , Aged , Anophthalmos/complications , Eye, Artificial/adverse effects , Female , Humans , Lacrimal Apparatus , Lacrimal Duct Obstruction/etiology , Male , Middle Aged , Radionuclide Imaging , Tears , Young Adult
8.
J Fr Ophtalmol ; 42(7): 696-702, 2019 Sep.
Article in French | MEDLINE | ID: mdl-31122762

ABSTRACT

PURPOSE: To define the best methods of evaluating conjunctival inflammation in patients with ocular prostheses. METHODS: The level of conjunctival inflammation and the patients' complaints were evaluated by several quantitative and qualitative methods : clinical grading, Schirmer's test, self-evaluation analogic scale of secretions, and a quality of life survey derived from the OSDI score (Ocular Surface Disease Index), initially designed for dry eye syndrome and modified to be relevant among this population. In order to test for consistency, the patients were re-evaluated for inflammation at the conclusion of 1 month of dexamethasone treatment, using the same methodology. The progression of each parameter under treatment was measured, searching for a correlation between improvement in the criteria and the patient's satisfaction. RESULTS: Twenty five patients were evaluated. The Schirmer's test did not change significantly with treatment. The clinical inflammation grade decreased significantly with treatment (p<0.0001) but was not correlated with patient satisfaction (p=0.63). The modified OSDI score and the self-evaluation analogic scale of secretions were both significantly improved (p<0.0001) and correlated with patient satisfaction (p=0.0048 for the OSDI, p<0.0001 for the analog scale). CONCLUSION: In our study, the most relevant tools to evaluate treatment efficacy for conjunctival inflammation in prosthetic eye wearers were the modified OSDI score and the self-evaluation analogic scale of secretions. The clinical grading scale is probably a good indicator for the biological effect of a treatment on the conjunctiva but may be unrelated to the patient's symptoms.


Subject(s)
Conjunctivitis/diagnosis , Eye, Artificial , Adrenal Cortex Hormones/therapeutic use , Conjunctiva/diagnostic imaging , Conjunctiva/pathology , Conjunctivitis/etiology , Conjunctivitis/pathology , Dry Eye Syndromes/drug therapy , Dry Eye Syndromes/etiology , Eye, Artificial/adverse effects , Humans , Inflammation/complications , Inflammation/diagnosis , Inflammation/pathology , Patient Satisfaction , Quality of Life , Severity of Illness Index , Treatment Outcome
11.
Clin Nucl Med ; 43(6): 445-446, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29659389

ABSTRACT

We present a case of an unexpected focally increased radiotracer uptake in an artificial eye in an FDG-PET/CT scan that was performed on a woman with a history of choroidal melanoma. It is crucial to know the type of prosthesis used and the timing of replacement for a correct interpretation of the findings. Recently, an FDG PET/CT was proposed to monitor the vascularity of the prosthesis instead of gadolinium MRI or of Tc bone scintigraphy.


Subject(s)
Eye, Artificial/adverse effects , Fluorodeoxyglucose F18/pharmacokinetics , Positron Emission Tomography Computed Tomography , Radiopharmaceuticals/pharmacokinetics , Female , Humans
12.
Semin Ophthalmol ; 33(1): 112-115, 2018.
Article in English | MEDLINE | ID: mdl-29144832

ABSTRACT

Reconstruction of the anophthalmic socket allows the use of an ocular prosthesis and rehabilitation of facial appearance. Dermis-fat grafting is one option in volume augmentation of the anophthalmic socket and presents unique benefits, including increased surface area within the socket and the ability to grow with pediatric patients. Postoperative complications of this procedure are relatively common. Minor complications, such as graft hirsutism, keratinization, and conjunctival cysts or granulomas, are managed easily by observation or simple intervention. Major complications, such as graft atrophy, infection, or ulceration, may prevent good prosthesis fit and may require return to the operating room.


Subject(s)
Adipose Tissue/transplantation , Anophthalmos/surgery , Dermis/transplantation , Eye, Artificial/adverse effects , Orbit/surgery , Orbital Implants/adverse effects , Postoperative Complications , Autografts , Humans
13.
Eye (Lond) ; 32(2): 439-445, 2018 02.
Article in English | MEDLINE | ID: mdl-29052604

ABSTRACT

PurposeTo assess tear cytokine levels and clinical outcomes in meibomian gland dysfunction (MGD) in the blind eye of patients wearing an ocular prosthesis after 2 months of treatment with topical loteprednol etabonate and eyelid scrubs with warm compresses.Patients and methodsThis study included patients with MGD wearing a unilateral ocular prosthesis for more than 1 year. All patients topically received 0.5% loteprednol etabonate and were instructed to scrub their eyelids with warm compresses on the prosthetic eye for 2 months. We evaluated tear cytokine levels using Multiplex Bead Immunoassays, performed biomicroscopic examination of the lid margins and meibomian gland, conducted meibography imaging, and assessed MGD-related ocular symptoms using a questionnaire for the prosthetic eye before and 2 months after treatment.ResultsThirty consecutive patients were included. There were significant reductions in the levels of interleukin (IL)-6, interferon-γ, monocyte chemotactic protein-1, IL-8, tumor necrosis factor-α, and IL-1ß (P<0.001 for each cytokine). Moreover, there were improvements in ocular symptoms (P=0.001), lid margin abnormalities (P<0.001), meibomian gland expressibility (P<0.001) and meibography findings (P=0.037).ConclusionTopical loteprednol etabonate in conjunction with eyelid scrubs and warm compresses were effective in treating MGD in prosthetic eye wearers. Furthermore, tear cytokine measurements may serve as an additional approach for evaluating the efficacy of anti-inflammatory treatment for MGD in prosthetic eye wearers.


Subject(s)
Anti-Allergic Agents/therapeutic use , Eye, Artificial/adverse effects , Eyelid Diseases/drug therapy , Loteprednol Etabonate/therapeutic use , Meibomian Glands , Administration, Topical , Adult , Aged , Anti-Allergic Agents/administration & dosage , Anti-Allergic Agents/pharmacology , Cytokines/metabolism , Eye Proteins/metabolism , Eyelid Diseases/metabolism , Eyelid Diseases/pathology , Female , Humans , Loteprednol Etabonate/administration & dosage , Loteprednol Etabonate/pharmacology , Male , Meibomian Glands/drug effects , Meibomian Glands/metabolism , Middle Aged , Prospective Studies , Tears/metabolism
14.
J Craniofac Surg ; 28(8): 1901-1905, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28922242

ABSTRACT

BACKGROUND: Osseointegrated implants have been used for craniofacial prosthetic reconstruction since 1979. The authors sought to review long-term outcomes of osseointegrated orbital reconstruction at the Institute for Reconstructive Sciences in Medicine (iRSM). METHODS: Twenty-six patients have undergone osseointegrated orbital prosthetic (OOP) reconstruction at iRSM since 1991. A retrospective chart review was performed and patient satisfaction assessed through a questionnaire used in previous osseointegration studies. Multivariate binary logistic regression analysis was performed to assess the relationship between smoking, age, sex, and previous radiation treatment with the occurrence of skin reactions and implant failures. A χ test was used to assess the relationship between implant position within the orbit and development of a skin reaction or implant failure. RESULTS: Patients received an average of 5.8 implants during the course of treatment. Follow-up ranged from 6 months to 24 years (mean = 10.6 years). A statistically significant correlation was found between skin reaction and age (P = 0.022), with younger patients more likely to develop a reaction. No variables in our model were significant for predicting implant failure. Overall, there were 39 failures of 155 osseointegrated implants, for a success rate of 74.8%. There was no relationship between skin reaction and implant failure compared to implant position within the orbit. Survey responses were received from 11 of 19 patients (58% response rate). Ninety-one percent of patients were overall satisfied with their prosthesis. CONCLUSIONS: There are minimal contraindications for consideration of OOP reconstruction. Patients find their prosthesis comfortable, report increased self-confidence, and are happy to have undergone reconstruction.


Subject(s)
Eye, Artificial/adverse effects , Facial Dermatoses/etiology , Orbit/surgery , Osseointegration , Prosthesis Failure/etiology , Adolescent , Adult , Aged , Child , Female , Follow-Up Studies , Humans , Male , Middle Aged , Patient Satisfaction , Prosthesis Implantation , Plastic Surgery Procedures , Retrospective Studies , Time Factors , Young Adult
15.
Acta Otorhinolaryngol Ital ; 37(6): 519-522, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28530256

ABSTRACT

Orbital exenteration is a disfiguring procedure performed for unresponsive orbital infections and control of recurrent benign tumours and malignancies arising from the eyelids (basal cell carcinoma, squamous cell carcinoma, conjunctival malignant melanoma), lachrymal glands (adenoid cystic carcinoma) or surrounding sinuses. In extremely rare cases the use of a prosthetic eye after enucleation can lead to anophthalmic socket tumours. We report the case of a 54-year-old man who had left eye enucleation due to recurring events of retinal detachment and who developed an invasive fast growing epidermoid carcinoma 30 years later. We review the literature to evaluate the rarity of the occurrence, time of onset after enucleation, treatments and outcomes. Our case illustrates the management of the pathology and emphasises the necessity of careful examination of the anophthalmic socket and the ocular prosthesis to identify any irregularities or damage on its surface even after exenteration that is not performed for malignant disease. Long-term follow up is necessary because this tumour could occur at long time periods after enucleation.


Subject(s)
Eye, Artificial/adverse effects , Orbital Neoplasms/etiology , Postoperative Complications/etiology , Eye Enucleation , Humans , Male , Middle Aged
16.
J Fr Ophtalmol ; 40(5): 403-407, 2017 May.
Article in English | MEDLINE | ID: mdl-28359626

ABSTRACT

PURPOSE: To evaluate the effect of femtosecond laser and excimer laser on an intracorneal inlay (KAMRA®) implanted in animal models. METHODS: Femtosecond laser was used to create corneal intrastromal pockets at 250µm depth in five porcine eyes. Four intact KAMRA inlays, examined by slit-lamp biomicroscopy and light microscopy, were implanted in the pocket of four eyes. A standard LASIK flap was created above each implanted inlay in the four eyes using a femtosecond laser with flap thicknesses of 150µm, 130µm, 110µm and 90µm. In the fifth porcine eye, a LASIK flap was created using femtosecond laser at 110µm depth, and a fifth inlay was then implanted in the 250µm pocket. Excimer laser ablation was performed under the flap targeting a -3.00 refraction. The inlay was then explanted, examined and reimplanted in the same pocket followed by a second similar excimer laser ablation. RESULTS: Significant burn, shrinkage and distortion of microholes were noted in all the first four inlays following the femtosecond laser flap creation at all the various flap thicknesses. The damage was noted to be more prominent as the distance between the flap and inlay decreased. No apparent effect was noted on the fifth inlay following repeated excimer laser ablations. CONCLUSION: Unlike excimer laser, femtosecond laser appears to be hazardous and damaging to the intracorneal KAMRA inlay when applied above it.


Subject(s)
Corneal Stroma/surgery , Keratomileusis, Laser In Situ/adverse effects , Lasers, Excimer/therapeutic use , Prostheses and Implants , Animals , Eye, Artificial/adverse effects , Lasers, Excimer/adverse effects , Models, Animal , Presbyopia/surgery , Prostheses and Implants/adverse effects , Prosthesis Implantation/adverse effects , Swine , Visual Acuity
18.
Rev. Assoc. Paul. Cir. Dent ; 70(2): 122-125, abr.-jun. 2016. ilus
Article in Portuguese | LILACS, BBO - Dentistry | ID: lil-797061

ABSTRACT

Objetivos: Este artigo visa exemplificar uma parceria internacional técnico cientifica por meio da utilização de técnica idealizada e patenteada por pesquisadores brasileiros. Materiais e Métodos: Um grupo de pesquisadores brasileiros idealizou, pesquisou e patenteou uma técnica de obtenção e utilização de íris digitalizada na reabilitação protética ocular. A internacionalização do método foi decorrente do intercâmbio estabelecido entre professores do Brasil e do México.A permanência do pesquisador mexicano, por um período em que especializou e concluiu o curso de mestrado, junto aos colegas brasileiros, pôde oferecer conhecimento e treinamento na aplicação da técnica proposta. Resultados: São apresentados casos clínicos em que a reabilitação protética ocular foi realizada usando a técnica brasileira de íris digitalizada. Conclusão:Pesquisas brasileiras, principalmente na área da saúde, vêm tendo destaque internacional. A preocupação com a melhora da qualidade de vida torna relevantes nossos estudos e técnica sem âmbito mundial.


Objectives: This article aims to illustrate a scientific technical international relation ship through the use of technique created and patented by Brazilian researchers. Materials and Methods: A group of Brazilian researchers devised, researched and patented a technique of obtaining and using scanned iris in ocular prosthetic rehabilitation. The internationalization of the technique was due to technical and scientific partner ship between Brazilian and Mexican researchers. A Mexican researcher remained for a period in which he specialized and completed his master’s course with the Brazilian team that was able to transfer knowledge and offer atraining in the application of the technique. Results: Three cases are shown, two Brazilian an done Mexican. Ocular Prosthetic rehabilitation of these cases was performed using the Brazilian technique of scanned iris. Conclusion: Brazilian research, especially in health, comes with international relevance. The concern with improving life quality makes our technical studies relevant world wide.


Subject(s)
Humans , Male , Female , Iris/metabolism , Eye, Artificial/adverse effects , Eye, Artificial/standards , Eye, Artificial , Rehabilitation/ethics , Rehabilitation/instrumentation , Rehabilitation/methods , Rehabilitation , Rehabilitation/trends
19.
Ophthalmologe ; 113(2): 133-42, 2016 Feb.
Article in German | MEDLINE | ID: mdl-26160105

ABSTRACT

BACKGROUND: Ocular prosthetics make a decisive contribution to the functional, esthetic and psychosomatic rehabilitation of patients after ocular extirpation. OBJECTIVES: This article provides an overview of the fitting, daily care and complications of ocular prosthetics. METHODS: The study comprised a PubMed literature review and own clinical results. RESULTS: Ocular prosthetics made from cryolite glass or perspex can be manufactured and fitted 5-8 weeks after removal of the eye. During this period a conformer is placed within the conjunctival sac in order to prevent scar formation and shrinking of the socket. Artificial eyes can be worn continuously, only interrupted by a short but regular cleaning procedure. Artificial tears and lid hygiene improve the comfort of wearing. Glass prostheses have to be renewed every 1-2 years, while perspex prostheses need to be polished once a year. Complications, such as giant papillary conjunctivitis or blepharoconjunctivitis sicca are facilitated by poor fit, increased age and inappropriate care of the prosthetic device. In the case of socket shrinkage or anophthalmic socket syndrome, surgical interventions are needed to re-enable the use of an artificial eye. CONCLUSION: Adequate fitting, daily care of ocular prosthetics and therapeutic management of associated complications are mandatory for a durable functional, esthetic and psychosomatic rehabilitation after ocular extirpation.


Subject(s)
Eye Enucleation/psychology , Eye Enucleation/rehabilitation , Eye, Artificial/adverse effects , Eye, Artificial/psychology , Prosthesis Fitting/methods , Prosthesis Fitting/psychology , Equipment Failure Analysis , Eye, Artificial/trends , Germany , Humans , Prosthesis Design/psychology , Prosthesis Failure , Prosthesis Fitting/trends , Treatment Outcome
20.
São Paulo; s.n; 2016. 68 p. ilus. (BR).
Thesis in Portuguese | LILACS, BBO - Dentistry | ID: biblio-868011

ABSTRACT

Introdução: A reconstrução de grandes defeitos da face nem sempre é passível de correção cirúrgica, podendo ser restaurados com as próteses faciais. Apesar da prótese óculopalpebral apresentar uma aparência natural, ela é facilmente notada, pois não apresenta os movimentos palpebrais de abertura e fechamento sincronizadas com o olho contralateral, tornando assim a reconstrução protética um grande desafio. Objetivos: Planejar, desenhar, viabilizar e construir um protótipo com recurso mecânico/elétrico possibilitando sincronia dos movimentos palpebrais com o olho sadio para utilização em prótese óculopalpebral. Material e Métodos: Confecção de uma prótese óculopalpebral com um dispositivo de pálpebra móvel em silicone médico capaz de conectar-se a um sistema mecânico-elétrico responsável por realizar movimentos de abertura e fechamento da pálpebra móvel da prótese. Resultados e Discussão: Foi confeccionada uma prótese óculo-palpebral em resina acrílica termicamente ativada, criando-se um nicho para a acomodação de um sistema elétrico e possibilitar a livre movimentação de uma fina pálpebra em silicone interligada ao dispositivo tornando possível a conexão desse sistema com um sensor que capta o movimento palpebral de um olho saudável. Conclusão: No presente estudo um protótipo mecânico - elétrico foi planejado, desenhado e desenvolvido acoplado a uma prótese óculopalpebral estabelecendo e sincronizando seus movimentos palpebrais com o olho sadio.


Introduction: Surgical reconstruction of large facial defects may not be always possible. Extraoral maxillofacial prosthesis are a good restorative option. Even though when the oculopalpebral prosthesis presents a natural appearance, it can be easily noticed because its eyelids do not move. It is desirable for the eyelids to open and close synchronously with contralateral eye. Thus, prosthetic reconstruction of oculopalpebral region is a great challenge. Objectives: To plan, design, enable and build a oculopalpebral prosthesis prototype with mechanical and electric features allowing eyelid motion with synchronization with the sound eye. Material and method: Fabrication of an oculopalpebral prosthesis with a medical grade silicone movable eyelid which has the capability to connect itself to an mechanical-eletrical system responsible to make opening and closing movements on prosthesis movable eyelid. Results and discussion: An oculopalpebral prosthesis was made in thermoactivated acrylic resin. A gap was created to accomodate an electrical system and also allow free motion of a thin silicone eyelid attached to the dispositive. This system can be connected to a sensor which captured the eyelid motion of a sound eye. Conclusion: A mechanical-electrical prototype was planned, designed and developed attached to an oculopalpebral prosthesis stablishing and synchronizing its eyelid movements with the sound eye.


Subject(s)
Humans , Male , Female , Adult , Prosthesis Design/ethics , Prosthesis Design/instrumentation , Prosthesis Design/methods , Eye, Artificial/adverse effects , Eye, Artificial , Maxillofacial Prosthesis/adverse effects , Maxillofacial Prosthesis/trends , Maxillofacial Prosthesis , Rehabilitation/organization & administration , Rehabilitation
SELECTION OF CITATIONS
SEARCH DETAIL
...